Your PK Modeling & Simulation Partner!

Based on Model-Informed Drug Development, PhInc. Modeling helps you to increase the confidence in decision making and reduces cycle time of your development.
PhinC. Services
 
Preclinical
First In Human
Phase I
PoC
Phases IIa IIb
Late development
Phase III
 
News
Join us

Careers

Discover our job offers!

We are regularly looking for dynamic and motivated applicants in pharmacometrics, data science, programming, biostatistics, etc.
Read more

They trust us

Sakina Sayah-Jeanne
Sakina Sayah-Jeanne
Senior Director, Translational R&D - Da Volterra
PhinC has been accompanying Da Volterra for several years on PBPK Modelling activities. Our collaboration, based on mutual trust, has already been very fruitful and has allowed Da Volterra to gain precious knowledge on its product under development. Da Volterra enjoys working with PhinC and will continue to do so in the years to come, leaning from its expertise.
Agnes Hemon
Agnes Hemon
Preclinical and P.K clinical Officer - HRA Pharma
PhinC is one of HRA Pharma’s valuable partners for pharmacokinetic studies. From just an advice to modelling, we know we can trust them to efficiently support and carry out our projects.
Olivier Lacombe
Olivier Lacombe
Head of Pharmacokinetics - Inventiva
Inventiva and PhinC have been collaborating for several years on popPK and PBPK modeling activities. The decision to work with PhinC was based on the team expertise in pharmacokinetics and modeling within drug development, and their aptitude to react and to collaborate within a biotech context. Moreover their approach is based on the client listening and project understanding in order to propose the most adequate proposal to the request. Our relationship is very pleasant, efficient and fruitful for both the scientific and project outputs.
Newsletter subscription
Contact
Follow us on LinkedIn
BioQuébec
Montreal International
GMP - Groupe de Métabolisme et Pharmacocinétique
EUFEMED
AFSSI
AFPT